InMode Ltd. logo
InMode Ltd. INMD
$ 14.91 0.47%
report update icon

Quarterly report 2025-Q4
added 05-06-2026

InMode Ltd. Balance Sheet 2025-2011 | INMD

Brief overview of InMode Ltd.'s assets and capital

This overview follows the five latest available annual observations between 2021 and 2025.

Assets advanced +60.2% to $766.4 million from $478.5 million; annual growth near 12.5% reflects a fast increase in scale.

Liability growth of +32.7% trailed asset growth of +60.2%. The funding structure became more resilient.

The equity-to-assets ratio is 89.1%, compared with 86.9% five periods ago. The balance sheet has a substantial internal cushion.

The period ended with net cash: net debt stood at -$294.3 million. This supports financial flexibility.

Retained earnings reached $968.5 million, changing +190% over the period. A positive accumulated result supports equity.

What the balance sheet shows

InMode Ltd.'s balance sheet looks resilient: assets are supported by substantial equity, while debt does not overwhelm financial flexibility.

Annual Balance Sheet InMode Ltd.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-294 M -148 M -135 M -94 M - - - -34.8 M -17.6 M - - - - - -

Long Term Debt

5.01 M 5.31 M 6.61 M 3.51 M - - - - - - - - - - -

Long Term Debt Current

3.22 M 2.51 M 2.4 M - - - - - - - - - - - -

Total Non Current Liabilities

12.5 M 12 M 11.8 M 7.77 M 10.9 M 5.26 M 6.09 M 4.76 M 6.53 M - - - - - -

Total Current Liabilities

70.7 M 69.9 M 64.1 M 82 M 51.8 M 35 M 32.5 M 29.4 M - - - - - - -

Total Liabilities

83.2 M 81.9 M 75.9 M 89.8 M 62.7 M 40.3 M 38.6 M 34.2 M 20 M - - - - - -

Deferred Revenue

12.1 M 16.8 M 10.9 M 13.8 M - 11.9 M - - 1.13 M - - - - - -

Retained Earnings

969 M 875 M 693 M 496 M 334 M 169 M 94 M 33 M 10.8 M - - - - - -

Total Assets

766 M 786 M 863 M 644 M 479 M 296 M 218 M 81.1 M 39.4 M - - - - - -

Cash and Cash Equivalents

303 M 155 M 144 M 97.5 M - 68.9 M 44.7 M 24.7 M 17.6 M - - - - - -

Book Value

683 M 704 M 787 M 555 M 416 M 255 M 180 M 46.9 M 19.5 M - - - - - -

Total Shareholders Equity

683 M 704 M 787 M 555 M 416 M 255 M 180 M 43.3 M 19.5 M - - - - - -

All numbers in USD currency

Quarterly Balance Sheet InMode Ltd.

2025-Q4 2024-Q4 2023-Q4 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

5.01 M 5.31 M 6.61 M - - - - 3.31 M - - - 358 K - - - 744 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

12.5 M 12 M 11.8 M - - - - 10.9 M - - - 5.26 M - - - 6.09 M - - - 4.76 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

83.2 M 81.9 M 75.9 M - - - - 62.7 M - - - 40.3 M - - - 38.6 M - - - 34.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

12.1 M 16.8 M 10.9 M - - - - 13.8 M - - - 11.9 M - - - 15.6 M - - - 5.76 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

969 M 875 M 693 M - - - - 334 M - - - 169 M - - - 94 M - - - 33 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

766 M 786 M 863 M - - - - 479 M - - - 296 M - - - 218 M - - - 81.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

303 M 155 M 144 M - - - - 68.1 M - - - 68.9 M - - - 44.7 M - - - 24.7 M - - - 17.6 M - - - 6.7 M - - - - - - - - - - - - - - - - - - - - - - -

Book Value

683 M 704 M 787 M - - - - 416 M - - - 255 M - - - 180 M - - - 46.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

683 M 704 M 787 M - - - - 416 M - - - 254 M - - - 176 M - - - 43.3 M - - - 19.5 M - - - 8.92 M - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of InMode Ltd., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
- - $ 162 M franceFrance
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.47 0.71 % $ 618 M israelIsrael
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 13.96 0.67 % $ 395 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Inogen Inogen
INGN
$ 5.42 0.18 % $ 144 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 126.5 0.8 % $ 4.39 B usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 22.41 1.17 % $ 526 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.35 0.03 % $ 21.8 M usaUSA
SmileDirectClub SmileDirectClub
SDC
- -53.45 % $ 9.71 M usaUSA
Sientra Sientra
SIEN
- -16.59 % $ 10.3 M usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
- - $ 1.07 B usaUSA
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Surgalign Holdings Surgalign Holdings
SRGA
- -32.98 % $ 1.68 M usaUSA
ShockWave Medical ShockWave Medical
SWAV
- - $ 12.3 B usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
LENSAR LENSAR
LNSR
$ 8.58 4.0 % $ 103 M usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
- -25.84 % $ 171 K usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
- 3.55 % $ 7.96 M usaUSA
Titan Medical Titan Medical
TMDI
- -26.32 % $ 19.6 M canadaCanada
LivaNova PLC LivaNova PLC
LIVN
$ 81.92 0.89 % $ 4.47 B britainBritain
Butterfly Network Butterfly Network
BFLY
$ 7.36 0.96 % $ 1.82 B usaUSA
Vapotherm Vapotherm
VAPO
- 6.72 % $ 34 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Globus Medical Globus Medical
GMED
$ 78.29 0.27 % $ 10.6 B usaUSA